Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 521-525

  Areman, E M ^a,b   Mazumder, A ^a   Kotula, P L ^a   Verma, U N ^a   Rajagopal, C ^a   Hancock, S ^a   Guevarra, C ^a   Djahanmir, M ^a   Sacher, R A ^a   Meehan, K R ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast cancer; Immunotherapy; Interleukin 2; PBSC

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; PACLITAXEL;

ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CELL CULTURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONY FORMING UNIT; CRYOPRESERVATION; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

BREAST NEOPLASMS; CELL SEPARATION; CELLS, CULTURED; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2;

EID: 10144253708     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kessinger A, Armitage JO, Landmark JD, Weiseburger DD. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 1986; 14: 192-196.
2. Juttner CA, To LB, Haylock DN et al. Autologous blood stem cell transplantation. Transplant Proc 1986; 21: 2929-2931.
3. Reiffers J, Bernard P, David B et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol 1986; 14: 312-315.
4. Reiffers J, Faberes C, Boiron J et al. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment. J Hematother 1994; 3: 185-191.
5. Linen DC, Burnett AK. Clinical studies of ABMT in acute myeloid leukemia. Clin Haematol 1986; 15: 167-186.
6. Butterini A, Bortin MM, Gale RP. Graft-versus-leukemia following bone marrow transplantation. Bone Marrow Transplant 1987; 2: 233-242.
7. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 341: 85-86.
8. Moss TJ, Ross AA. The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematother 1992; 1: 225-232
9. Moss TJ. Sensitive detection of metastatic tumor cells in bone marrow. In: Gee AP, Gross S, Worthington-White DA (eds). Advances in Bone Marrow Purging and Processing, Fourth International Symposium. New York: Wiley-Liss, 1994, pp 567-577.
10. Kaiser H, Stuart RK, Brookmeyer R et al. Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclosphosphamide to purge tumor cells. Blood 1985; 65: 1504-1510.
11. Ramsay N, Le Bien T, Nesbit M et al. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 1986; 66: 508-513.
12. Gorin NC, Douay L, Laporte JP et al. Autologous bone marrow transplantation using marrow incubated with Asia Z 7557 in adult acute leukemia. Blood 1986; 67: 1367-1376.
13. Kvalheim G, Sorensen O, Fodstad O et al. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Bone Marrow Transplant 1988; 3: 31-41.
14. Ball ED, Mills LE, Cornwell III GG et al. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow. Blood 1990; 75: 1199-1206.
15. Charak BS, Malloy B, Agah R, Mazumder A. A novel approach to purging of leukemia by activation of bone marrow with interleukin-2. Bone Marrow Transplant 1990; 6: 193-198.
16. Charak BS, Areman EM, Dickerson SA et al. A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application. Bone Marrow Transplant 1993; 11: 147-154.
17. Verma U, Areman E, Dickerson SA et al. Interleukin-2 activation of chemotherapy and growth factor-mobilized peripheral blood stem cells for generation of cytotoxic effectors. Bone Marrow Transplant 1995; 15: 199-206.
18. Meehan KR, Rajagopal CR, Verma LJ et al. Stem cell transplantation with interleukin-2 (IL-2) and high dose chemotherapy for breast cancer. Blood 1995; 86: 389a (Abstr.).
19. Charak BS, Brynes RK, Groshen S et al. Bone marrow transplantation with interleukin-2-activated bone marrow followed by interleukin-2 therapy for acute myeloid leukemia in mice. Blood 1990; 76: 2187-2190.
20. Elias AD, Ayash L, Anderson KC et al. Mobilizaton of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036-3044.
21. Kaminer LS, Williams FF, Beschorner J et al. High-dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma. Bone Marrow Transplant 1989; 4: 359-362.
22. Joshi SS, Kessinger A, Mann SL et al. Detection of malignant cells in histologically normal bone marrow using culture techniques. Bone Marrow Transplant 1987; 1: 303-310.
23. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991: 77: 1717-1722.
24. Charak BS, Agah R, Brynes RK et al. Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective. Bone Marrow Transplant 1992; 9: 1-8.
25. Charak BS, Brynes RK, Katsuda S et al. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin therapy. Cancer Res 1991; 51: 2015-2020.
26. Fritsch G, Emminger W, Buchinger P et al. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1991; 19: 1079-1083.
27. Serke S, Sauberlich S, Huhn D. Multiparameter flow-cytometrical quantitation of circulating CD34(+) cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony assay. Br J Haematol 1991; 77: 453-459.
28. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-341.
29. Kanz L, Lohr G, Fauser A. Lymphokines from isolated T lymphocyte subpopulations support multilineage hematopoietc colony and megakaryocyte colony formation. Blood 1986; 68: 991-995.
30. Sullivan R, Hesketh P, McCarroll L, Zuckerman K. Production of erythroid burst-promoting activity (BPA) and granulocyte-monocyte colony-stimulating activity (GM-CSA) by isolated human T-lymphocyte subpopulations. Exp Hematol 1986; 14: 659-667.